CPT code 52214 identifies transurethral endoscopic destruction (fulguration or ablation) of abnormal tissue in the bladder trigone, bladder neck, prostatic fossa, urethra, or periurethral glands using electrocautery, cryosurgery, or laser. This procedure is a focused urologic intervention commonly used to treat localized lesions, bleeding sources, or obstructive tissue within the lower urinary tract. Nationally, accurate coding of this procedure affects clinical documentation, procedural quality tracking, and payer adjudication for urology services.

Key payers highlighted in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication offers a concise review of how CPT code 52214 is defined, typical sites of service (ambulatory surgical centers and hospital operating rooms), and the clinical contexts in which it is used.

Readers will find benchmarks and coding guidance relevant to billing and claims processing, summaries of payer coverage patterns where available, and clinical context to support accurate charge capture and recordkeeping. The content summarizes common documentation elements associated with the procedure and notes where input data was not provided.